Altimmune Sector: Dual GLP-1/glucagon receptor agonists for obesity and liver disease HQ: Gaithersburg, MD Year Founded: 1997 Origin Story: Altimmune originally focused on infectious disease vaccines and biodefense, including a formative all-stock merger with PharmAthene, a US biodefense drug specialist
It works in a similar way to other GLP-1 medications such as Wegovy and Mounjaro
Description T10mg: Research Dual Incretin Agonist (GLP-1 / GIP Pathways) 1 GLP-TIRZ (10mg) Key Features Dual-pathway incretin research peptide (GLP-1R + GIPR) Lyophilized for stability and accurate laboratory handling QC verified for identity and batch consistency T10mg: Research Dual Incretin Agonist (GLP-1 / GIP Pathways) 1 GLP-TIRZ (10mg) Key Features Dual-pathway incretin research peptide (GLP-1R + GIPR) Lyophilized for stability and accurate laboratory handling QC verified for identity and batch consistency
2011;2011(5):15 Albillos A and Tejedor M
Peptides often interfere with endotoxin detection due to their tendency to bind or mask endotoxins, which can lead to inaccurate low results
Check the packaging and labels A sure sign that youre dealing with a fake is misspellings on the label, or poor print quality
